表紙
市場調査レポート

世界の子宮頸癌検査(Pap Smear/HPV)診断市場の見通し:国別の検査件数、売上予測およびサプライヤーのシェア

Pap Smear/Human Papillomavirus (HPV): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

発行 Venture Planning Group 商品コード 237650
出版日 ページ情報 英文 257 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。

Local License: 同一事業所内

Back to Top
世界の子宮頸癌検査(Pap Smear/HPV)診断市場の見通し:国別の検査件数、売上予測およびサプライヤーのシェア Pap Smear/Human Papillomavirus (HPV): US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
出版日: ページ情報: 英文 257 Pages
概要

当レポートでは、世界の主要国(フランス・ドイツ・イタリア・日本・スペイン・英国・米国) における子宮頸癌検査(Pap Smear/HPV)市場について調査分析し、世界市場と技術の概要、各国市場の現状と将来予測を提供するほか、 主な製品開発機会、市場参入戦略などを検証し、主要企業プロファイルも含め、 概略以下の構成でお届けいたします。

目次

I. イントロダクション

II. 世界市場と技術の概要

A. 子宮頸癌検査: 臨床的意義および検査実習

B. 装置・機器類 概説および市場ニーズ

  • 1. Abbott AxSYM
  • 2. Abbott IMx
  • 3. Anagen AN2000/AuraFlex
  • 4. Beckman Coulter Access
  • 5. BioChem Pharma SR1
  • 6. bioMerieux Vidas Series
  • 7. Biotrol Systems 7000
  • 8. J&J Diagonostics/Amersham Amerlite
  • 9. J&J Diagonostics Vitros ECI
  • 10. Olympus PK Series
  • 11. Roche Cobas Core
  • 12. Roche Elecsys
  • 13. Roche ES 22
  • 14. Roche ES 33
  • 15. Roche ES 300/300 AL
  • 16. Siemens ACS: 180
  • 17. Siemens ACS: Centaur
  • 18. Siemens ELISA Processor II/III
  • 19. Siemens Immuno 1
  • 20. Siemens/Opus/Plus/Magnum
  • 21. Siemens Stratus
  • 22. Tosoh AIA Series
  • 23. Wallac/Pharmacia Delfia

C. 最新技術

  • 1. モノクローナル/ポリクローナル抗体
  • 2. 免疫学的測定法
  • 3. 分子診断検査
  • 4. バイオチップ/マイクロアレイ
  • 5. 染色体分析
  • 6. マイクロコンピュータおよびオートメーション
  • 7. 人工知能
  • 8. フローサイトメトリー
  • 9. バイオセンサー

D. 競合/補完的技術

  • 1. CT
  • 2. MRI
  • 3. NMR
  • 4. PET
  • 5.光工学スペクトロスコピー

E. 個人検査

III. フランス: 検査件数および診断用薬 売上予測 (市場セグメント別)

IV. ドイツ: 検査件数および診断用薬 売上予測 (市場セグメント別)

V. イタリア: 検査件数および診断用薬 売上予測 (市場セグメント別)

VI. 日本: 検査件数および診断用薬 売上予測 (市場セグメント別)

VII. スペイン: 検査件数および診断用薬 売上予測 (市場セグメント別)

VIII. 英国: 検査件数および診断用薬 売上予測 (市場セグメント別)

IX. 米国: 検査件数および診断用薬 売上予測 (市場セグメント別)

X. 分散型検査製品の設計基準

XI. 代替市場浸透戦略

  • A. 内部開発
  • B. 共同開発
  • C. 大学との提携
  • D. 流通戦略
    • 1. マーケティングアプローチ
    • 2. 製品の複雑さ
    • 3. 顧客選好
    • 4. 確立された供給業者
    • 5. 新たな供給業者
    • 6. 主要なタイプの卸売り業者
    • 7. 市場細分化要因

XII. 潜在市場の参入障壁およびリスク

  • A. 市場の成熟化
  • B. コスト抑制
  • C. 競争
  • D. 技術面での優位性と限界
  • E. 特許保護
  • F. 規制上の制約
  • G. 分散型検査市場の課題

XIII. 競合プロファイル

  • Abbott
  • AdnaGen
  • Ambrilia Biopharma
  • AMDL
  • Beckman Coulter
  • Becton Dickinson
  • Biomedica Diagonostics
  • bioMerieux
  • Bio-Rad
  • CanAG Diagonostics
  • CeMines
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • J&J Diagonostics
  • Kreatech
  • Kyowa Medex
  • Mackay Life Sciences
  • Matritech
  • Myriad Genetics
  • OncoLab
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagonostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac
  • Zila

表一覧

  • 主要な開発/販売企業; 子宮頸癌検査 検査
  • フランス 子宮頸癌検査 検査件数および診断用薬 (市場セグメント別)
  • ドイツ 子宮頸癌検査 検査件数および診断用薬 (市場セグメント別)
  • イタリア 子宮頸癌検査 検査件数および診断用薬 (市場セグメント別)
  • 日本 子宮頸癌検査 検査件数および診断用薬 (市場セグメント別)
  • スペイン 子宮頸癌検査 検査件数および診断用薬 (市場セグメント別)
  • 英国 子宮頸癌検査 検査件数および診断用薬 (市場セグメント別)

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCA18880
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the Pap Smear/HPV testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 257 pages and 21 tables

Table of Contents

I. Introduction

II. PAP SMEAR/HPV Worldwide Market and Technology Overview

  • A. PAP Smear/HPV: Clinical Significance and Laboratory Practices
  • B. Instrumentation Review And Market Needs
    • 1. Abbott AxSYM
    • 2. Abbott Architect c4000
    • 3. Abbott Architect i2000 Series
    • 4. Abbott Architect ci8200 System
    • 5. Beckman Coulter UniCel Series
    • 6. Beckman Coulter Access
    • 7. Binding Site ESP600
    • 8. bioMerieux Mini Vidas
    • 9. Carolina Chemistries BioLis 24i
    • 10. DiaSorin Liaison
    • 11. Horiba ABX Pentra 400
    • 12. Inverness DS2
    • 13. J&J Vitros ECi/ECiQ
    • 14. J&J Vitros 3600
    • 15. J&J Vitros 5600
    • 16. Olympus AU5400
    • 17. Olympus AU3000i
    • 18. Olympus AU2700
    • 19. Roche Modular Analytics
    • 20. Roche Cobas Integra 400
    • 21. Roche Cobas Integra 400 Plus
    • 22. Roche Elecsys
    • 23. Roche Cobas c311
    • 24. Siemens ADVIA Centaur
    • 25. Siemens Dimension
    • 26. Siemens Dimension RxL Max
    • 27. Siemens Dimension Vista 500
    • 28. Siemens Immulite
    • 29. Siemens Stratus
    • 30. Tosoh AIA-Series
    • 31. Vital Diagnostics ATAC 8000
    • 32. Vital Diagnostics Envoy 500

C. Current and Emerging Technologies

  • 1. Monoclonal and Polyclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Radioimmunoassay (RIA)
    • c. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Immunofiltration
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • d. Fluorescent Immunoassays
    • e. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • f. Latex Agglutination
    • g. Immunoprecipitation
    • H. Affinity Chromatographu
    • e. Liposome Flow-Injection Immunoassay
  • 3. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • PCR
      • DAP-PCR
      • Immuno-PCR
      • QC-PCR
      • CAR
      • DNA
      • HPA
      • LCR
      • NASBA
      • QBR
      • SDA
      • 3 SR, and others
  • 4. Chromosome Analysis
    • a. Chronic Myelogenous Leukemia (CML)
    • b. Acute Myeloid Leukemia (AML)
    • c. Acute Lymphoblastic Leukemia (ALL)
    • d. Malignant Lymphomas
    • Lymphoid Malignancies
    • e. Chronic Lymphocytic Leukemia (CLL)
    • f. Solid Cancers
    • g. Chromosomal Translocation and Oncogenes
  • 5. Artificial Intelligence
  • 6. Flow Cytometry
  • 7. Two Dimensional Gel Electrophoresis (2-DGE)
  • 8. Biosensors
  • 9. Competing/Complementing Technologies
    • a. CT
    • b. MRI
    • c. NMR
    • d. PET
    • e. Photonics Spectroscopy

E. Personal Testing

III. France: Test Volume and Diagnostics Sales Forecast by Market Segment

IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment

V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment

VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment

VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment

VIII. U.K.: Test Volume and Diagnostics Sales Forecast by Market Segment

IX. U.S.A.: Test Volume and Diagnostics Sales Forecast by Market Segment

X. Design Criteria for Decentralized Testing Products

XI. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation Factor

XII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

XIII. Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

List of Tables

  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • France PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • France Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • Germany Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • Italy Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • Japan Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • Spain Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. PAP Smear Test Volume and Diagnostics Sales by Market Segment
  • U.K. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A. Papillomavirus(HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
Back to Top